Healthcare - Biotechnology - NASDAQ - US
$ 6.56
39.6 %
$ 24 M
Market Cap
-2.2
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
55.65%
EBIT
Estimate
--22.00%
Net Income
Estimate
29.07%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Pulmatrix, Inc.
PULM has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart PULM
EBIT FORECAST
EBIT Forecast Chart PULM
NET INCOME FORECAST
Net Income Chart PULM